MedTrace Logo

Registry of Vaccine Responses in Immune Compromised Patients

NCT06463119 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-11-07

No results posted yet for this study

Summary

The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.

Conditions

  • Immunosuppression

Interventions

OTHER

Collection of data in a registry

The aim of this observational project is to document the immunogenicity and reactogenicity of vaccines given to immunocompromised patients and collect it in a registry.

Sponsors & Collaborators

  • Laure Pittet, MD-PhD

    lead OTHER

Principal Investigators

  • Laure F Pittet, MD-PhD · University Hospitals of Geneva

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-24
Primary Completion
2029-04-30
Completion
2029-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06463119 on ClinicalTrials.gov